Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 4
1993 2
1994 3
1995 3
1996 2
1997 1
1999 5
2000 2
2001 1
2002 4
2003 4
2004 3
2005 2
2006 4
2007 4
2008 6
2009 3
2010 5
2011 7
2012 12
2013 10
2014 7
2015 3
2016 2
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Contraception.
Szarewski A, Guillebaud J. Szarewski A, et al. BMJ. 1991 May 25;302(6787):1224-6. doi: 10.1136/bmj.302.6787.1224. BMJ. 1991. PMID: 2043843 Free PMC article. Review. No abstract available.
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group. Paavonen J, et al. Among authors: szarewski a. Lancet. 2009 Jul 25;374(9686):301-14. doi: 10.1016/S0140-6736(09)61248-4. Epub 2009 Jul 6. Lancet. 2009. PMID: 19586656 Clinical Trial.
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, Chow SN, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David MP, Descamps D, Struyf F, Dubin G; HPV PATRICIA Study Group. Lehtinen M, et al. Among authors: szarewski a. Lancet Oncol. 2012 Jan;13(1):89-99. doi: 10.1016/S1470-2045(11)70286-8. Epub 2011 Nov 8. Lancet Oncol. 2012. PMID: 22075171 Clinical Trial.
HPV vaccine: Cervarix.
Szarewski A. Szarewski A. Expert Opin Biol Ther. 2010 Mar;10(3):477-87. doi: 10.1517/14712591003601944. Expert Opin Biol Ther. 2010. PMID: 20132062 Review.
Discussion.
Milsom I, Szarewski A, Killick S, Roumen F, Vree M. Milsom I, et al. Among authors: szarewski a. Eur J Contracept Reprod Health Care. 2002 Dec;7(sup2):37-39. doi: 10.1080/13625187.2002.11949334. Eur J Contracept Reprod Health Care. 2002. PMID: 29243952 No abstract available.
New technologies and procedures for cervical cancer screening.
Cuzick J, Bergeron C, von Knebel Doeberitz M, Gravitt P, Jeronimo J, Lorincz AT, J L M Meijer C, Sankaranarayanan R, J F Snijders P, Szarewski A. Cuzick J, et al. Among authors: szarewski a. Vaccine. 2012 Nov 20;30 Suppl 5:F107-16. doi: 10.1016/j.vaccine.2012.05.088. Vaccine. 2012. PMID: 23199953 Review.
Prophylactic HPV vaccines.
Szarewski A. Szarewski A. Eur J Gynaecol Oncol. 2007;28(3):165-9. Eur J Gynaecol Oncol. 2007. PMID: 17624079 Review.
Public awareness of human papillomavirus.
Cuschieri KS, Horne AW, Szarewski A, Cubie HA. Cuschieri KS, et al. Among authors: szarewski a. J Med Screen. 2006;13(4):201-7. doi: 10.1177/096914130601300408. J Med Screen. 2006. PMID: 17217610 Review.
95 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page